Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neuron-specific enolase

¹Department of Chemical Pathology, University of Leeds, UK.

The International Journal of Biological Markers

|October 1, 1994

Summary

This summary is machine-generated.

Neuron-specific enolase (NSE) shows clinical value as a marker for small cell lung cancer, neuroblastoma, melanoma, and seminoma. Its role in central nervous system diseases is also reviewed.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database.

Pediatric surgery international·2023

Same author

Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.

The Journal of rheumatology·1996

Same author

Serum hyaluronan concentrations predict survival in patients with chronic renal failure on maintenance haemodialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1996

Same author

Bone alkaline phosphatase in rheumatic diseases.

Annals of clinical biochemistry·1995

Same author

Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.

The International journal of biological markers·1995

Same author

Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer.

The Prostate·1994

Same journal

The diagnostic and predictive value of miR-145-3p in gastric cancer and its regulation of gastric cancer progression via targeting CREB1.

The International journal of biological markers·2026

Same journal

PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancer.

The International journal of biological markers·2026

Same journal

Luminex assay of plasma IL-6, TNF-α, leptin, and adiponectin: Impact of anticoagulants, single-well analysis, and freeze-thaw stability.

The International journal of biological markers·2026

Same journal

Expression of concern: "RIPK4 is Downregulated in Poorly Differentiated Tongue Cancer and is Associated with Migration/Invasion and Cisplatin-Induced Apoptosis".

The International journal of biological markers·2026

Same journal

Association of NF-kappaBIA rs696 gene polymorphism with breast cancer risk in Bangladeshi women: A case-control study.

The International journal of biological markers·2026

Same journal

Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions.

The International journal of biological markers·2026

See all related articles

Area of Science:

Oncology
Neurology
Biomarker Research

Background:

Neuron-specific enolase (NSE) is an established biomarker.
Its utility spans various cancers and neurological conditions.

Purpose of the Study:

To review the clinical value of NSE in specific cancers.
To discuss the role of NSE in central nervous system (CNS) diseases.

Main Methods:

Literature review of studies on NSE.
Analysis of NSE levels in serum and cerebrospinal fluid (CSF).

Main Results:

NSE is a valuable marker for small cell lung cancer, neuroblastoma, melanoma, and seminoma.
NSE levels are relevant in both benign and malignant CNS diseases.

Conclusions:

NSE has established clinical significance in diagnosing and monitoring specific malignancies.
Further understanding of NSE's role in CNS disorders is warranted.